Search clinical trials for: Faslodex
Total 284 results
-
F2G Biotech GmbHQuotient ClinicalWithdrawnInvasive Aspergillosis
-
University of Wisconsin, MadisonAstraZeneca; University of PittsburghWithdrawnCarcinoma, Non Small Cell Lung
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Baylor Breast Care CenterTerminatedBREAST CANCERUnited States
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Regina Elena Cancer InstituteAstraZenecaUnknown
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
National Cancer Institute (NCI)WithdrawnEstrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian CancerUnited States
-
Hellenic Oncology Research GroupCompleted
-
AstraZenecaDendrix - Scientific Information ArchitectureCompleted
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Venezuela, Colombia, Poland, Malta, Mexico
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Massachusetts General Hospital; Dana-Farber Cancer... and other collaboratorsActive, not recruiting
-
AstraZenecaCompletedPuberty, Precocious | McCune-Albright SyndromeItaly, United States, Germany, France, Russian Federation, United Kingdom
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
Fresenius KabiCompleted
-
Isabel BlancasCompletedMalignant Neoplasm of Breast Stage IVSpain
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
AstraZenecaActive, not recruitingAdvanced Metastatic Breast CancerUnited States
-
Atossa Therapeutics, Inc.TerminatedFemale Breast Carcinoma | Female Ductal Carcinoma In SituUnited States
-
M.D. Anderson Cancer CenterEli Lilly and Company; AstraZenecaActive, not recruitingMalignant Neoplasms of Female Genital OrgansUnited States
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
Scorpion Therapeutics, Inc.RecruitingBreast Cancer | Gynecologic Cancer | HNSCC | Solid Tumors, AdultUnited States, Spain
-
Novartis PharmaceuticalsActive, not recruiting
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, France, Spain, United Kingdom, Austria, Germany, Taiwan, Australia, Italy, Israel, Russian Federation, Korea, Republic of, Hong Kong, Thailand, Canada, Hungary, Japan, Lebanon, Belgium, Bulgaria, Greece, Argentina, Peru, Czech... and more
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States